Hepatocellular carcinoma(HCC)is one of the most common malignant tumors of the liver,with poor prognosis and high mortality.Traditional treatments for patients with HCC have shown poor efficacy especially for advanced...Hepatocellular carcinoma(HCC)is one of the most common malignant tumors of the liver,with poor prognosis and high mortality.Traditional treatments for patients with HCC have shown poor efficacy especially for advanced liver cancer.Compared with other organs,the liver has more natural immune cells such as Kupffer cells,natural killer cells and natural killer T cells.Immunotherapy for liver cancer has become the focus in current research.The theoretical basis of immunotherapy rests on immune tolerance and suppression in the tumor microenvironment.Common immunotherapy methods include vaccines,cytokines,adoptive cell therapies,immune checkpoint inhibitors,and oncolytic viruses.Compared with traditional treatment,immunotherapy can enhance the body’s immune function,delay tumor progression,and prolong survival.This article reviews the HCC microenvironment and immunotherapy both in the clinical and basic research aspects.展开更多
基金This study was funded by the National Natural Science Foundation of China(grant number 81670111).
文摘Hepatocellular carcinoma(HCC)is one of the most common malignant tumors of the liver,with poor prognosis and high mortality.Traditional treatments for patients with HCC have shown poor efficacy especially for advanced liver cancer.Compared with other organs,the liver has more natural immune cells such as Kupffer cells,natural killer cells and natural killer T cells.Immunotherapy for liver cancer has become the focus in current research.The theoretical basis of immunotherapy rests on immune tolerance and suppression in the tumor microenvironment.Common immunotherapy methods include vaccines,cytokines,adoptive cell therapies,immune checkpoint inhibitors,and oncolytic viruses.Compared with traditional treatment,immunotherapy can enhance the body’s immune function,delay tumor progression,and prolong survival.This article reviews the HCC microenvironment and immunotherapy both in the clinical and basic research aspects.
